Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the ...
dvm3603h
USDA approves new canine cancer therapy
ELIAS Animal Health, a companion animal cancer therapeutics company, shared today that the USDA Center for Veterinary ...
University of Oslo19h
IN5490 – Advanced Topics in Artificial Intelligence for Intelligent Systems
Attend at least 80% of all seminar sessions. It will also be counted as one of your three attempts to sit the exam for this course, if you sit the exam for one of the following courses: IN9490 – ...